Last reviewed · How we verify

NCT05610423

Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway

ENROLLING BY INVITATION Last updated 1 August 2023
What this trial tests

trial testing no intervention in Myocarditis in 100 participants. Enrolling by invitation.

Timeline
1 September 2022
Primary endpoint
31 December 2032
31 December 2032

Quick facts

Lead sponsorOslo University Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment100
Start date1 September 2022
Primary completion31 December 2032
Estimated completion31 December 2032
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

5 and older, any sex, with Myocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a national multicenter study in Norway investigating of individuals with Covid-19 vaccine associated myocarditis (VAM) and pericarditis in Norway. The main objective is to validate the reported possible cases of Covid-19 vaccine associated myo-and pericarditis in Norway as well as investigate for predisposing factors and risk factors for developing these vaccine adverse events. Furthermore, patients with confirmed Covid-19 VAM, will be invited to participate in a prospective cohort study, investigating for cardiac long-term adverse effects 1 year and 2 years after vaccine-associated myocarditis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Myocarditis after COVID-19 mRNA vaccination in Norway: a nationwide validation study.
    Hagen BS, Vlaisavljevic K, Oppedal LS, Endresen J, et al · · 2026 · PMID 42082376 · DOI 10.1136/openhrt-2026-004112

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Myocarditis

Currently open trials in the same condition.

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05610423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing